Performance Comparison of Microfluidic and Immunomagnetic Platforms for Pancreatic CTC Enrichment
November 15, 2025
Brand Name :
Masteron
Synonyms :
drostanolone
Class :
Androstanes, Steroids
Dosage Forms & Strengths Â
Injectable solution  Â
1.4 mg/kg Â
1.4 mg/kg is given intramuscularly thrice a week
Pediatric Â
Not determined
Refer to the adult dosing regimenÂ
Actions and spectrumÂ
Drostanolone has anabolic properties; thus, it can stimulate protein synthesis and promote muscle growth. Â
Frequency not definedÂ
Facial hair Â
Coarser skinÂ
Hypertriglyceridemia Â
Hoarseness Â
Coarser skin
 Black box warningÂ
None Â
Contraindication/Caution:Â Â
The drug is contraindicated in following situations:Â
HypersensitivityÂ
Prostate Cancer Â
Breast CancerÂ
Pregnancy Warnings:Â Â
Pregnancy category: N/AÂ Â
Lactation:Â Â
Excretion of the drug in human breast milk is unknown Â
Pregnancy categories:Â Â Â Â
Category A: Satisfactory and well-controlled studies show no evidence of risk to the fetus in the first trimester or in the later trimester.   Â
Category B: No evidence of risk to fetus found in animal reproduction studies and there are not enough studies on pregnant women.   Â
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women.   Â
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category clearly outweigh risks over benefits. These category drugs should be prohibited for pregnant women.   Â
Category N: There is no data available for the drug under this category.Â
Pharmacology:Â Â
This drug is derived from dihydrotestosterone. It works by binding it to androgen receptors. Â
Pharmacodynamics:Â
The anabolic properties of drostanolone stimulate protein synthesis and promote skeletal muscle growth. Â
Pharmacokinetics:Â
Limited information is available on ADME.  Â
Administration:Â Â
It is administered into the muscles, i.e., intramuscular route, as an injection. Â
Â
Patient information leaflet Â
Generic Name: drostanolone Â
Why do we use drostanolone? Â
It is used to treat postmenopausal breast carcinoma.Â
It gives a muscular appearance to the muscles due to its anabolic androgenic steroid class. Â